申请人:——
公开号:US20040063686A1
公开(公告)日:2004-04-01
Compounds of formula (I) in which: each A is independently hydrogen, C1-6alkyl optionally substituted by hydroxyl, C1-6alkoxy, C1-6alkenyl or C1-6acyl group or a halogen atom or hydroxyl, CN or CF3 group; R3 is hydrogen, methyl or ethyl; R4 is an optionally substituted aromatic carbocyclic or heterocyclic ring; Z is an O or S atom, or an NH or CH2 group, or a single bond, at the 3 or 4 position of R4 relative to the carbonyl group; R5 is an optionally substituted aromatic carbocyclic or heterocyclic ring, or an optionally substituted, saturated or unsaturated, carbocyclic or heterocyclic ring; and Q is (a) Where X, Y, R1 and R2 are as defined in claim 1; are antagonists of a human 11CBy receptor.
1
化合物的公式(I)如下:其中:每个A都是独立的氢,C1-6烷基,可选择性地被氢氧基,C1-6氧烷基,C1-6烯基或C1-6酰基或卤素原子或氢氧基,CN或CF3基替代;R3是氢,甲基或乙基;R4是一个可选择性替代的芳香环或杂环;Z是O或S原子,或NH或CH2基,或与羰基相对的R4的3或4位置上的单键;R5是可选择性替代的芳香环或杂环,或可选择性替代的饱和或不饱和的芳香环或杂环;Q是(a)其中X,Y,R1和R2如权利要求1所定义;是人类11CBy受体的拮抗剂。